Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 24, 2026 07:00 ET | Source: Li Auto Inc.

Li Auto Inc. Announces US$1.0 billion Share Repurchase Program

BEIJING, China, March 24, 2026 (GLOBE NEWSWIRE) -- Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that its board...
March 24, 2026 07:00 ET | Source: Rezolute, Inc.

Rezolute Provides Update on its Congenital Hyperinsulinism Program Following FDA Meeting

REDWOOD CITY, Calif., March 24, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by all...
March 24, 2026 07:00 ET | Source: Outlook Therapeutics, Inc.

Outlook Therapeutics Announces Pricing of $5.0 Million Public Offering

ISELIN, N.J., March 24, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of...
March 24, 2026 07:00 ET | Source: Aben Gold Corp.

Aben Gold Corp. Assesses Historical Tungsten Results from 2014 Re-Assay Program and Plans 2026 Exploration Program to Target Both Tungsten and Gold at the Justin Project

Vancouver, BC, March 24, 2026 (GLOBE NEWSWIRE) -- Aben Gold Corp. (TSX-V: ABM) (OTCID: ABNAF) (Frankfurt: ML1) (“Aben” or “the Company”) is pleased to announce that it is actively assessing the...
March 24, 2026 07:00 ET | Source: CAMP4 Therapeutics

CAMP4 Appoints Michael MacLean to its Board of Directors

CAMBRIDGE, Mass., March 24, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of...
March 24, 2026 06:41 ET | Source: Yimutian Inc.

Yimutian Inc. Provides 2026 Strategic Update: Financing on Track, Management to Purchase No Less Than US$3 Million in Company Shares, Full-Year Revenue Expected to Reach RMB 1 Billion

BEIJING, March 24, 2026 (GLOBE NEWSWIRE) -- Yimutian Inc. (the "Company") today issued a strategic update to investors and market participants, outlining the Company's capital plan, equity...
March 24, 2026 06:30 ET | Source: Amaze Holdings, Inc

Amaze and LA Times Studios to Launch Food Channel LA, a Next-Generation Creator-led Commerce Platform

New Platform Marks LA Times Studios’ Move into Social Commerce Built Through Amaze’s Operating Studio Model, the Platform Will Combine the LA Times Studios Brand Power with Amaze’s End-to-End...
March 24, 2026 06:30 ET | Source: Bimergen Energy Corporation

Bimergen Energy to Present its $2B Growth Strategy at the Emerging Growth Virtual Conference on April 2nd

Newport Beach, CA, March 24, 2026 (GLOBE NEWSWIRE) -- Bimergen Energy Corporation (NYSE American: BESS, BESS.WS), a developer, owner, and operator of utility-scale and distributed battery energy...
March 24, 2026 06:00 ET | Source: Quotient Therapeutics, Inc.

Quotient Therapeutics Announces Collaboration with Merck to Discover Novel Drug Targets in Inflammatory Bowel Disease Using Somatic Genomics Platform Technology

CAMBRIDGE, Mass., March 24, 2026 (GLOBE NEWSWIRE) -- Quotient Therapeutics, a company pioneering somatic genomics to inform breakthrough medicines, today announced that it has entered a multi-year...
March 24, 2026 04:00 ET | Source: Global Licensing Group

Netflix’s Chief Marketing Officer, Marian Lee, Takes Center Stage at Licensing Expo 2026 for an Opening Keynote on the Netflix Effect and Fandom

Licensing Expo announces the keynote featuring Marian Lee, Chief Marketing Officer of Netflix, in a session moderated by License Global on fan engagement